SUPN
Supernus Pharmaceuticals, Inc.
stockNASDAQ
Market OpenOct 29, 2026 9:37:12 AM EDT
43.68USD+6.329%(+2.60)36,503
Pre-marketOct 29, 2026 9:27:30 AM EDT
43.40USD+5.648%(+2.32)
SUPN Financials
In Q2 FY 2026 (ended ), Supernus Pharmaceuticals, Inc. (SUPN) reported revenue of $219.06M, net income of −$58.37M, operating cash flow of −$4.81M, and assets of $1.43B.
Loading financial statements…